Cardiac hypertrophy and fibrosis were attenuated by olive leaf extract treatment in a rat model of diabetes

The key role of fibrosis and hypertrophy processes in developing diabetes‐induced heart injury has been demonstrated. Considering the known hypoglycemic effects of olive leaf extract (OLE), we decided to investigate its potential effect and associated mechanisms on cardiac fibrosis and myocardial hypertrophy in streptozotocin (STZ)‐induced diabetic rats. Eight groups were included in this study: control, diabetic, diabetic‐OLEs (100, 200 and 400 mg/kg), diabetic‐metformin (300 mg/kg), diabetic‐valsartan (30 mg/kg), and diabetic‐metformin/valsartan (300/30 mg/kg). After a treatment period of 6 weeks, echocardiography was used to assess cardiac function. Heart‐to‐body weight ratio (HW/BW) and fasting blood sugar (FBS) were measured. Myocardial histology was examined by Masson's trichrome staining. Gene expressions of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), β–myosin heavy chain (β‐MHC), TGF‐β1, TGF‐β3, angiotensin II type 1 receptor (AT1), alpha‐smooth muscle actin (α‐SMA), and collagen were evaluated by the quantitative real‐time PCR in heart tissue. A reduction in the FBS level and HW/BW ratio in the extract groups was obvious. The improvement of left ventricular dysfunction, cardiac myocytes hypertrophy, and myocardial interstitial fibrosis was also observed in treated groups. A lowering trend in the expression of all hypertrophic and fibrotic indicator genes was evident in the myocardium of OLE treated rats. Our data indicated that OLE could attenuate fibrosis and reduce myocardial hypertrophy markers, thus improving the cardiac function and structure in the STZ‐induced diabetic rats. Practical applications This study demonstrates that olive leaf extract in addition to lowering blood glucose levels and the heart‐to‐body weight ratio (HW/BW) may also improve cardiac function and reduce cardiac hypertrophy and fibrosis in cardiac tissue, which leads to inhibition of diabetic heart damage. Thus it is possible that including olive leaf extracts in the diets of individuals with diabetes may assist in lowering cardiovascular disease risk factors. The effects of olive leaf extract in diabetic cardiomyopathy were evaluated. Diabetes was induced by single dose STZ‐injection in rats. FBS and Heart‐to‐body weight ratio were reduced in all treated rats. Olive leaf extract ameliorated oxidative stress in heart tissue of diabetic rats. Cardiac hypertrophy and fibrosis were diminished in treated rats. Left ventricular dysfunction was improved